![Alan Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Huang
Consultant / Advisor chez
Casdin Capital /Private Equity/
Profil
Alan Huang is currently an Advisor at Casdin Capital since 2021.
Prior to this, he was the Chief Scientific Officer at Tango Therapeutics, Inc. from 2018 to 2023.
He worked at Novartis AG as a Senior Director from 2009 to 2015 and at Novartis Institutes of Biomedical Research as a Senior Director & Global Head-Oncology from 2003 to 2016.
He also worked as a Senior Scientist at Millennium Pharmaceuticals, Inc. Additionally, he holds a doctorate degree from the University of South Alabama, which he received in 1998, and an undergraduate degree from Fudan University, which he received in 1993.
Postes actifs de Alan Huang
| Sociétés | Poste | Début |
|---|---|---|
Casdin Capital /Private Equity/
 Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital invests in companies located in the United States. The firm focus on life sciences, healthcare, biotechnology, synthetic biology, and technology sectors. It provides financing for early and growth stage capital requirements. | Consultant / Advisor | 01/03/2021 |
Anciens postes connus de Alan Huang
| Sociétés | Poste | Fin |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 06/10/2023 |
Novartis Institutes of Biomedical Research
 Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Operates pharmaceutical research organization | Corporate Officer/Principal | 01/01/2016 |
Novartis AG /U.S. Biologics Manufacturing Operation/
 Novartis AG /U.S. Biologics Manufacturing Operation/ Pharmaceuticals: MajorHealth Technology Manufactures Bayer's Betaseron, a pharmaceutical product | Directeur/Membre du Conseil | 31/12/2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Directeur Technique/Scientifique/R&D | - |
Formation de Alan Huang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
University of South Alabama
 University of South Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis AG /U.S. Biologics Manufacturing Operation/
Novartis AG /U.S. Biologics Manufacturing Operation/ Pharmaceuticals: MajorHealth Technology Manufactures Bayer's Betaseron, a pharmaceutical product | Health Technology |
Casdin Capital /Private Equity/
Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital invests in companies located in the United States. The firm focus on life sciences, healthcare, biotechnology, synthetic biology, and technology sectors. It provides financing for early and growth stage capital requirements. | Finance |
Novartis Institutes of Biomedical Research
Novartis Institutes of Biomedical Research BiotechnologyHealth Technology Operates pharmaceutical research organization | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
